Arch Venture Fund VIII Overage LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arch Venture Fund VIII Overage LP
CIK #0001617237
EDGAR Form CIK 2011 - 2026
3 [0001617237]
4 [0001617237]
D [0001617237]
Form 3/4/5 Subject 2011 - 2026
Arch Venture Partners X LLC
Arch Venture Partners VIII LLC
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Neumora Therapeutics Inc
Arch Venture Fund X LP
Arch Venture Fund VII LP
Arch Venture Fund VIII Overage LP
Arch Venture Partners X Overage LP
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Arch Venture Partners VIII LP
Bybee Clinton
Nelsen Robert
Codiak BioSciences Inc
Arch Venture Fund VIII LP
Crandell Keith
Quanterix Corp
Arch Venture Partners VI LP
Arch Venture Fund VI LP
Arch Venture Partners VI LLC
Metacrine Inc
Q32 Bio Inc
Sienna Biopharmaceuticals Inc
Twist Bioscience Corp
Unity Biotechnology Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 703,061
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 1,176,593
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 684,167
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Buy 1,500,000 $17.00 25,500,000
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,576,400
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Series B Preferred Stock · derivative
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,576,400
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 684,167
Codiak BioSciences Inc CDAK
Warrant (Right to Buy) · derivative
2022-09-13 Buy 5,000,000
Codiak BioSciences Inc CDAK
Common Sotck
2022-09-13 Buy 5,000,000 $1.50 7,500,000
Quanterix Corp QTRX
Common Stock
2020-11-24 Other 1,036 $0.00
Quanterix Corp QTRX
Common Stock
2020-11-24 Other 1,034 $0.00
Quanterix Corp QTRX
Common Stock
2020-11-24 Other 176,920 $0.00
Quanterix Corp QTRX
Common Stock
2020-11-24 Other 277,514 $0.00
showing 20 of 95 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com